Adaptive Biotechnologies (ADPT) Inventory Average (2019 - 2026)

Adaptive Biotechnologies has disclosed Inventory Average across 8 years of filings, most recently posting $10.5 million for Q1 2026.

• Inventory Average for Q1 2026 came in at $10.5 million, up 22.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.5 million (up 22.79% YoY), and the FY2025 annual result was $9.1 million, down 20.22% from the prior year.
• Inventory Average came in at $10.5 million for Q1 2026 at Adaptive Biotechnologies, up from $9.9 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $20.1 million in Q1 2022 to a low of $8.5 million in Q2 2025.
• The 5-year median for Inventory Average is $13.9 million (2024), against an average of $14.3 million.
• Across the five-year window, Inventory Average climbed 27.89% in 2022 and plunged 39.91% in 2024, its largest moves.
• Adaptive Biotechnologies' Inventory Average stood at $15.9 million in 2022, then increased by 6.73% to $17.0 million in 2023, then slumped by 39.91% to $10.2 million in 2024, then retreated by 3.15% to $9.9 million in 2025, then advanced by 6.44% to $10.5 million in 2026.
• The last three Inventory Average figures came in at $10.5 million (Q1 2026), $9.9 million (Q4 2025), and $9.2 million (Q3 2025), per Business Quant data.